Boji Shenzhou announced the latest results of two RATIONALE studies of Bai Ze An at the World Congress on Lung Cancer.

Baize Shenzhou announced today that the final analysis results of the RATIONALE-315 study and the long-term follow-up data of the RATIONALE-303 study showed that Baizean achieved clinically significant overall survival benefits in both studies. The specific data will be presented in the form of brief oral reports and posters at the 2025 World Lung Cancer Congress.